Diane D Liu Selected Research

Diane D Liu Research Topics

Disease

52	Neoplasms (Cancer) 01/2023 - 05/2002
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 05/2002
15	Breast Neoplasms (Breast Cancer) 10/2023 - 10/2011
10	Lung Neoplasms (Lung Cancer) 12/2019 - 01/2003
9	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2003
7	Pain (Aches) 11/2021 - 01/2018
6	Carcinogenesis 04/2014 - 01/2002
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2011 - 12/2005
4	Fatigue 12/2021 - 01/2016
4	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 04/2009
4	Adenocarcinoma of Lung 07/2013 - 01/2011
4	Carcinoma (Carcinomatosis) 05/2011 - 07/2002
3	Pathologic Complete Response 01/2020 - 10/2011
3	Adenocarcinoma 04/2011 - 04/2009
2	Triple Negative Breast Neoplasms 01/2024 - 01/2023
2	Cancer Pain 01/2021 - 01/2020
2	Dyspnea (Shortness of Breath) 01/2019 - 01/2016
2	Infections 02/2018 - 07/2002
2	Agranulocytosis (Granulocytopenia) 02/2018 - 07/2002
2	Nausea 01/2018 - 12/2015
2	Glioma (Gliomas) 01/2014 - 04/2009
2	Brain Neoplasms (Brain Tumor) 01/2014 - 05/2009
2	Metaplasia 02/2010 - 02/2003
2	Squamous Cell Carcinoma of Head and Neck 06/2007 - 12/2005
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2023
1	Long Term Adverse Effects 12/2021
1	Chronic Disease (Chronic Diseases) 11/2021
1	Obesity 01/2021
1	Sarcopenia 01/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021
1	Breast Carcinoma In Situ 01/2020
1	Ependymoma 01/2020
1	Hyperplasia 01/2020
1	Medulloblastoma 01/2020
1	Circulating Neoplastic Cells 01/2020
1	Poisoning 01/2020
1	Inflammatory Breast Neoplasms 01/2020

Drug/Important Bio-Agent (IBA)

9	Opioid Analgesics (Opioids)IBA 01/2021 - 12/2017
8	Proteins (Proteins, Gene)FDA Link 04/2014 - 03/2005
6	Estrogen ReceptorsIBA 10/2023 - 08/2007
6	ErbB Receptors (EGF Receptor)IBA 01/2016 - 04/2005
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2002
3	Messenger RNA (mRNA)IBA 01/2023 - 09/2002
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2016
3	Docetaxel (Taxotere)FDA Link 02/2018 - 04/2009
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2018 - 04/2005
3	Bevacizumab (Avastin)FDA Link 01/2016 - 04/2005
3	Carboplatin (JM8)FDA LinkGeneric 06/2015 - 04/2009
3	Tyrosine Kinase InhibitorsIBA 06/2015 - 04/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2015 - 11/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014 - 04/2005
3	RetinoidsIBA 07/2005 - 02/2003
2	Phosphotransferases (Kinase)IBA 01/2024 - 01/2023
2	Protons (Proton)IBA 01/2021 - 01/2021
2	Celecoxib (Celebrex)FDA Link 01/2020 - 02/2010
2	Cisplatin (Platino)FDA LinkGeneric 02/2018 - 11/2003
2	Morphine (MS Contin)FDA LinkGeneric 01/2018 - 12/2017
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2018 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2016 - 01/2003
2	Monoclonal AntibodiesIBA 03/2015 - 04/2005
2	Transcription Factors (Transcription Factor)IBA 07/2013 - 08/2008
2	Progesterone Receptors (Progesterone Receptor)IBA 02/2012 - 08/2007
2	Cadherins (E-Cadherin)IBA 05/2009 - 03/2005
2	alpha-Tocopherol FDA Link 01/2009 - 03/2005
2	Cyclin D1IBA 01/2009 - 02/2003
2	Insulin-Like PeptidesIBA 07/2006 - 07/2005
2	retinoic acid receptor betaIBA 02/2003 - 01/2003
1	src-Family KinasesIBA 10/2023
1	Aromatase InhibitorsIBA 10/2023
1	Dasatinib (BMS 354825)FDA Link 10/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	AntigensIBA 01/2023
1	Protein Subunit VaccinesIBA 01/2023
1	Bexarotene (LGD1069)FDA Link 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	HER2 peptide (369-377)IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021
1	talimogene laherparepvecIBA 11/2021
1	GlutaminaseIBA 01/2021
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2021
1	Radium-223IBA 01/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 12/2019
1	BenzodiazepinesIBA 12/2019

Therapy/Procedure

20	Therapeutics 10/2023 - 02/2003
12	Palliative Care (Palliative Therapy) 11/2021 - 01/2017
10	Chemoprevention 10/2023 - 01/2002
7	Drug Therapy (Chemotherapy) 01/2021 - 05/2010
7	Radiotherapy 01/2021 - 12/2005
6	Neoadjuvant Therapy 01/2020 - 10/2011
2	Physical Therapy Modalities (Physical Therapy Technique) 12/2021 - 01/2021
2	Immunotherapy 11/2021 - 01/2011
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 01/2021
2	Perioperative Period 02/2018 - 03/2014
1	Continuity of Patient Care 10/2021
1	Patient Transfer (Patient Dumping) 10/2021
1	Preoperative Exercise 01/2021
1	Intraventricular Infusions 01/2020
1	Precision Medicine 12/2019